Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05365412

Clinicopathological Characteristics of Colon Cancer in Young Age

A Study on the Characteristics of Colorectal Cancer by Age and sex.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Colo-rectal Cancer Colonic Diseases Colonic Neoplasms Colorectal Neoplasms Digestive System Diseases Digestive System Neoplasms Gastrointestinal Diseases Gastrointestinal Neoplasms Intestinal Diseases Intestinal Neoplasms Molecular Pathway Deregulation Neoplasms Neoplasms by Site Rectal Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Seoul National University Bundang Hospital

Seongnam-si, Gyeonggi-do, 463-707, South Korea

Location status: Recruiting

Location contact

Nayoung Kim, M.D.,Ph.D.

PRINCIPAL_INVESTIGATOR

Yonghoon Choi, M.D.

CONTACT

[email protected]

+82-31-787-7088

About this study

The investigators aimed to investigate the prognosis according to sex and age by analyzing the clinical, pathophysiological, and molecular characteristics of colorectal cancer (CRC), and to find the factors influencing the prognosis of CRC.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients treated after being diagnosed with colorectal cancer

Exclusion criteria

  • Patients under age of 18 years, or patients who cannot choose whether to participate or not
  • Patients who refuse to participate in the study

Treatment and study plan

Primary outcomes

  1. Survival (overall/disease-specific) according to sex, molecular profiles and sex hormone receptors

    Time frame: From date of enrollment until the date of death from colorectal cancer or from any cause, assessed up to 120 months

    Time from diagnosis to death

Secondary outcomes

  1. Disease-free survival according to sex, molecular profiles and sex hormone receptors

    Time frame: From date of enrollment until the date of first documented recurrence of colorectal cancer, assessed up to 120 months

    Time from diagnosis to recurrence

Study contacts

Contact information is provided by the study sponsor or research team.

Nayoung Kim, MD, PhD

CONTACT

[email protected]

+82-31-787-7009

Sponsors and collaborators

Lead sponsor

Seoul National University Bundang Hospital

Other

Registry information

Important dates

Study start
2019
Primary completion
2026
Study completion
2026
First posted
May 9, 2022
Registry last updated
Apr 28, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.